---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-22-000546"
form_type: "8-K"
ticker: "BIVI"
cik: "0001580149"
company_name: "BIOVIE INC."
filed_at: "2022-12-06T23:59:59+00:00"
generated_at: "2026-06-21T08:52:44.853502+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# BioVie increases ATM offering capacity from $8.1M to $17.5M under sales agreement

## Summary
- Filed prospectus supplement on Dec. 6, 2022 to raise maximum aggregate offering from $8.1M to $17.5M.
- Previously issued and sold 1,934,871 shares for net proceeds of approximately $7.4M (after ~$228K in fees).
- Shares sold via Controlled Equity Offering through agents Cantor Fitzgerald & Co. and B. Riley Securities.
- Up to $17.5M in additional shares of Class A common stock may now be sold under the at-the-market program.
- Prospectus supplement filed due to increase in public float since prior supplement dated Sept. 30, 2022.

## SEC filing metadata
- accession: 0001520138-22-000546
- form_type: 8-K
- ticker: BIVI
- cik: 0001580149
- company_name: BIOVIE INC.
- filed_at: 2022-12-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580149/000152013822000546/0001520138-22-000546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580149/000152013822000546/bivi-20221206_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-22-000546
- JSON: https://secwatch.observer/filing/0001520138-22-000546.json
- Plain text: https://secwatch.observer/filing/0001520138-22-000546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.